<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="de358060-f54a-4f36-a0d5-3f34122aba53"><labelDrug name="Teveten HCT"><Normalization><mmtx cui="C1170659" preferredWord="Teveten HCT" semType="phsu, orch"/></Normalization></labelDrug><generic name="Eprosartan Mesylate and Hydrochlorothiazide"/><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1" text="Drug Label for drug brand Teveten HCT, containing Eprosartan Mesylate and Hydrochlorothiazide." type="negative"><entity charOffset="0:19" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Teveten HCT," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="74:93" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="50:69" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.2" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="Eprosartan Mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="26:37" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.3" text="teveten hct" type="Biomedical_Entity"><Normalization><mmtx cui="C1170659" phraseText="Drug Label for drug brand Teveten HCT," preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.3"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.1.e.2"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.9" text="Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs." type="negative"><entity charOffset="131:142" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.9.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="hypersensitivity to other sulfonamide-derived drugs." preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="15:34" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.9.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Because of the hydrochlorothiazide component," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.9.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.9.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10" lineNumber="21" text="Do not co-administer aliskiren with TEVETEN HCT in patients with diabetes (see PRECAUTIONS, Drug Interactions )." type="regular"><entity charOffset="0:20" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.1" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="65:73" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="21:30" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with TEVETEN HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.4" text="TEVETEN HCT" type="Drug"><Normalization><mmtx cui="C1170659" phraseText="aliskiren with TEVETEN HCT" preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.1"><relations><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.2" ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.4" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.10.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.19" text="Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents. " type="negative"><entity charOffset="198:221" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.19.e.0" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="75:91" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.19.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="to antihypertensive use" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="168:179" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.19.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system from other antihypertensive agents." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.19.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.19.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.19.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.19.e.2"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27" text="Eprosartan mesylate, alone or in combination with hydrochlorothiazide, has been shown to produce maternal and fetal toxicities (maternal and fetal mortality, low maternal body weight and food consumption, resorptions, abortions and litter loss) in pregnant rabbits given oral doses as low as 10 mg eprosartan/kg/day and 3 mg hydrochlorothiazide/kg/day. " type="negative"><entity charOffset="298:308" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.0" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="as 10 mg eprosartan/kg/day" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.1" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="Eprosartan mesylate," preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="325:344" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="3 mg hydrochlorothiazide/kg/day." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="50:69" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.27.e.3"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28" text="No maternal or fetal adverse effects were observed in rabbits at 3 mg eprosartan/kg/day alone or in combination with 1 mg/kg/day of hydrochlorothiazide, this oral dose yielded a systemic exposure (AUC) to unbound eprosartan approximately equal to the human systemic exposure achieved with the dose of eprosartan mesylate contained in the maximum recommended human dose of TEVETEN HCT (600 mg eprosartan/day). " type="negative"><entity charOffset="385:402" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.0" text="600 mg eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C1125965" phraseText="human dose of TEVETEN HCT (600 mg eprosartan/day" preferredWord="eprosartan 600 MG" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="132:151" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="of hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="372:383" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.2" text="teveten hct" type="Biomedical_Entity"><Normalization><mmtx cui="C1170659" phraseText="human dose of TEVETEN HCT (600 mg eprosartan/day" preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><entity charOffset="301:320" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.3" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="achieved with the dose of eprosartan mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="213:223" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.4" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="(AUC) to unbound eprosartan" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="70:80" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.5" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="at 3 mg eprosartan/kg/day" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.5" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.3"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.4"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.5" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.5" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.3"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.5" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.28.e.3"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29" text="No adverse effects on in utero or postnatal development and maturation of offspring were observed when eprosartan mesylate was administered to pregnant rats at oral doses up to 1000 mg eprosartan/kg/day (the 1000 mg eprosartan/kg/day dose in non-pregnant rats yielded systemic exposure to unbound eprosartan approximately 0.8 times the exposure achieved in humans given 600 mg/day). " type="negative"><entity charOffset="297:307" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.0" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="systemic exposure to unbound eprosartan approximately 0.8 times" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="103:122" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.1" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="eprosartan mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="185:195" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.2" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="up to 1000 mg eprosartan/kg/day" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="216:226" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.3" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="the 1000 mg eprosartan/kg/day dose in non-pregnant rats" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.29.e.3"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.33" text="In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients (e.g., those being treated with diuretics), symptomatic hypotension may occur. " type="negative"><entity charOffset="134:143" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.33.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="treated with diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.33.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="with an activated renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.33.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.33.e.0"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.41" text="Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="0:19" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.41.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="23:34" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.41.e.1" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="a sulfonamide," preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.41.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.41.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48" lineNumber="49" text="Lithium Interaction: Lithium generally should not be given with thiazides (see PRECAUTIONS, Drug Interactions, Hydrochlorothiazide, Lithium )." type="irregular"><entity charOffset="46:58" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.1" text="not be given" type="Caution_Interaction"/><entity charOffset="21:28" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.2" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="64:73" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.3" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.3"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.48.e.3"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.53" text="Thiazides may decrease urinary calcium excretion. " type="negative"><entity charOffset="0:9" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.53.e.0" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="31:38" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.53.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="urinary calcium excretion." preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.53.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.53.e.1"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.54" text="Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism. " type="negative"><entity charOffset="63:70" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.54.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="slight elevation of serum calcium" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.54.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.54.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.54.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57" lineNumber="57" text="In diabetic patients, dosage adjustment of insulin or oral hypoglycemic agents may be required. " type="irregular"><entity charOffset="22:39" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.1" text="dosage adjustment" type="Caution_Interaction"/><entity charOffset="54:78" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.2" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="43:50" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.3" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="dosage adjustment of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="dosage adjustment of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="dosage adjustment of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="3:20" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.4" text="diabetic patients" type="SPAN"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.4"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.57.e.3"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.60" text="The antihypertensive effects of hydrochlorothiazide may be enhanced in postsympathectomy patients." type="negative"><entity charOffset="32:51" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.60.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="The antihypertensive effects of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="4:20" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.60.e.1" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="The antihypertensive effects of hydrochlorothiazide" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.60.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.60.e.0"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.62" text="Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals. " type="negative"><entity charOffset="64:75" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.62.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="possible electrolyte imbalance" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="32:44" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.62.e.1" text="electrolytes" type="Biomedical_Entity"><Normalization><mmtx cui="C0013832" phraseText="Periodic determination of serum electrolytes to" preferredWord="Electrolytes" semType="inch, phsu"/><RxNorm RxCui="3793"/></Normalization></entity><pair ddi="false" e1="" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.62.e.0"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.63" text="All patients receiving thiazide therapy should be observed for clinical signs of fluid or electrolyte imbalance: hyponatremia, hypochloremic alkalosis, and hypokalemia. " type="negative"><entity charOffset="90:101" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.63.e.0" text="electrolyte" type="Biomedical_Entity"><Normalization><mmtx cui="C3536863" phraseText="electrolyte imbalance" preferredWord="Electrolyte [EPC]" semType="phsu"/><RxNorm RxCui="3793"/></Normalization></entity><entity charOffset="23:31" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.63.e.1" text="thiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="thiazide therapy" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.63.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.63.e.0"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73" text="As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function have been reported in susceptible individuals treated with angiotensin II antagonists, in some patients, these changes in renal function were reversible upon discontinuation of therapy. " type="negative"><entity charOffset="158:172" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.0" text="angiotensin ii" type="Biomedical_Entity"><Normalization><mmtx cui="C0003009" phraseText="treated with angiotensin II antagonists," preferredWord="Angiotensin II" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="53:64" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin-aldosterone system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.73.e.1"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74" text="In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure), treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. " type="negative"><entity charOffset="174:214" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.0" text="angiotensin-converting enzyme inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="treatment with angiotensin-converting enzyme inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.1" text="aldosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0002006" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="1312358"/></Normalization></entity><entity charOffset="73:84" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="depend on the activity of the renin-angiotensin-aldosterone system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="219:254" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.3" text="angiotensin ii receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0521942" phraseText="angiotensin II receptor antagonists" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.3"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.3"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.74.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90" lineNumber="72" text="Potassium Supplements: A patient receiving TEVETEN HCT should be told not to use potassium supplements or salt substitutes containing potassium without consulting the prescribing physician (see PRECAUTIONS, Drug Interactions, Eprosartan Mesylate )." type="regular"><entity charOffset="70:80" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.1" text="not to use" type="Caution_Interaction"/><entity charOffset="81:102" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.2" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="43:54" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.3" text="TEVETEN HCT" type="Drug"><Normalization><mmtx cui="C1170659" phraseText="A patient receiving TEVETEN HCT" preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><entity charOffset="106:143" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.4" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium without consulting" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.2" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.4" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.90.e.4"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.92" text="Dual Blockade of the Renin-Angiotensin System (RAS)" type="negative"><entity charOffset="27:38" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.92.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="5:13" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.92.e.1" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Dual Blockade of the Renin-Angiotensin System" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.92.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.92.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93" lineNumber="79" text="Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="128:139" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="80:89" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="30:59" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.3" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="141:153" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.6" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:184" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.8" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="196:215" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.10" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.4"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.ddi.2"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.4"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.ddi.3"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.4"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.ddi.4"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.4"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.93.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94" lineNumber="79" text="Closely monitor blood pressure, renal function and electrolytes in patients on TEVETEN HCT and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.1" text="monitor" type="Caution_Interaction"/><entity charOffset="79:90" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.2" text="TEVETEN HCT" type="Drug"><Normalization><mmtx cui="C1170659" phraseText="on TEVETEN HCT" preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><entity charOffset="101:127" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.1"><relations><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.3" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.94.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95" lineNumber="80" text="Do not co-administer aliskiren with TEVETEN HCT in patients with diabetes. " type="regular"><entity charOffset="0:20" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.1" text="Do not co-administer" type="Caution_Interaction"/><entity charOffset="65:73" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.3" text="TEVETEN HCT" type="Drug"><Normalization><mmtx cui="C1170659" phraseText="aliskiren with TEVETEN HCT" preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><entity charOffset="21:30" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with TEVETEN HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.1"><relations><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.2" ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.3" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.95.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96" lineNumber="80" text="Avoid use of aliskiren with TEVETEN HCT in patients with renal impairment (GFR 60 ml/min)." type="regular"><entity charOffset="0:5" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="28:39" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.2" text="TEVETEN HCT" type="Drug"><Normalization><mmtx cui="C1170659" phraseText="with TEVETEN HCT" preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><entity charOffset="57:73" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.3" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="13:22" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.3" ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.2" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.96.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97" text="Eprosartan Mesylate: Eprosartan has been shown to have no effect on the pharmacokinetics of digoxin and the pharmacodynamics of warfarin and glyburide. " type="negative"><entity charOffset="0:19" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.0" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="Eprosartan Mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="128:136" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.1" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="the pharmacodynamics of warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="21:31" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.2" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="Eprosartan" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="92:99" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.3" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="no effect on the pharmacokinetics of digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="141:150" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.4" text="glyburide" type="Biomedical_Entity"><Normalization><mmtx cui="C0017628" phraseText="glyburide." preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.3"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.4"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.4"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.3"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.4"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.97.e.4"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99" text="Because eprosartan is not metabolized by the cytochrome P450 system, inhibitors of CYP450 enzyme would not be expected to affect its metabolism, and ketoconazole and fluconazole, potent inhibitors of CYP3A and 2C9, respectively, have been shown to have no effect on eprosartan pharmacokinetics. " type="negative"><entity charOffset="266:276" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.0" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="no effect on eprosartan pharmacokinetics." preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="149:161" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.1" text="ketoconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0022625" phraseText="ketoconazole" preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="166:177" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.2" text="fluconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0016277" phraseText="fluconazole," preferredWord="Fluconazole" semType="phsu, orch"/><RxNorm RxCui="4450"/></Normalization></entity><entity charOffset="8:18" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.3" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="eprosartan" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="69:96" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.4" text="inhibitors enzyme" type="Biomedical_Entity"><Normalization><mmtx cui="C0014432" phraseText="inhibitors of CYP450 enzyme" preferredWord="Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.99.e.4"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.100" text="Ranitidine also has no effect on eprosartan pharmacokinetics. " type="negative"><entity charOffset="0:10" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.100.e.0" text="ranitidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0034665" phraseText="Ranitidine also" preferredWord="Ranitidine" semType="phsu, orch"/><RxNorm RxCui="203136"/></Normalization></entity><entity charOffset="33:43" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.100.e.1" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="no effect on eprosartan pharmacokinetics." preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.100.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.100.e.1"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101" text="Eprosartan (up to 400 mg b.i.d. or 800 mg q.d.) doses have been safely used concomitantly with a thiazide diuretic (hydrochlorothiazide). " type="negative"><entity charOffset="0:10" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.0" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="Eprosartan" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="116:135" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="(hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="97:114" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.2" text="thiazide diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C3536861" phraseText="concomitantly with a thiazide diuretic" preferredWord="Thiazide Diuretic [EPC]" semType="phsu"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.1"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.101.e.1"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102" text="Eprosartan doses of up to 300 mg b.i.d. have been safely used concomitantly with sustained-release calcium channel blockers (sustained-release nifedipine) with no clinically significant adverse interactions. " type="negative"><entity charOffset="99:123" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.0" text="calcium channel blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0006684" phraseText="concomitantly with sustained-release calcium channel blockers" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.1" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="Eprosartan doses of" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="143:153" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.2" text="nifedipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028066" phraseText="(sustained-release nifedipine" preferredWord="Nifedipine" semType="phsu, orch"/><RxNorm RxCui="7417"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.2"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.102.e.2"/></sentence><sentence biomedicalEntities="7" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103" lineNumber="81" text="As with other drugs that block angiotensin II or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements or salt substitutes containing potassium may lead to increases in serum potassium (see PRECAUTIONS, Information for Patients, Potassium Supplements )." type="regular"><entity charOffset="81:108" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.1" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="concomitant use of potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="116:130" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.2" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="132:143" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.4" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="145:154" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.6" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="232:260" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.8" text="increases in serum potassium" type="Specific_Interaction"/><entity charOffset="157:178" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.9" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="182:219" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.10" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="14:60" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.11" text="drugs that block angiotensin II or its effects" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="As with other drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0003009" phraseText="angiotensin II" preferredWord="Angiotensin II" semType="bacs, phsu, aapp"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.2" drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.1"/><drugClassMembership drug="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.4" drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.1"/><drugClassMembership drug="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.6" drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.1"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.9"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.10"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.11" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.1" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.11" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.9" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.11" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.10" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.8" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.9"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.10"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.9" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.103.e.10"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.104" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors)" type="negative"><entity charOffset="88:104" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.104.e.0" text="cox-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="(COX-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><entity charOffset="0:38" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.104.e.1" text="non-steroidal anti-inflammatory agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="Non-Steroidal Anti-Inflammatory Agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="59:86" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.104.e.2" text="cyclooxygenase-2 inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C1257954" phraseText="Selective Cyclooxygenase-2 Inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="119049"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.104.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.104.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.104.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.104.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105" lineNumber="85" text="In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including eprosartan, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="141:147" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.1" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="159:185" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.2" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="192:227" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.4" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="239:249" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.5" text="eprosartan" type="Drug"><Normalization><mmtx cui="C0287041" phraseText="eprosartan," preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="265:296" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.7" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="20:27" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.8" text="elderly" type="SPAN"/><entity charOffset="92:118" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.9" text="compromised renal function" type="SPAN"/><entity charOffset="29:44" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.10" text="volume-depleted" type="SPAN"/><entity charOffset="317:336" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.12" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.2"/><drugClassMembership drug="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.5" drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.4"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.7"><relations><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.8"/></relation><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.ddi.2"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.12"><relations><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.8"/></relation><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.10"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.8, Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.9, Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.10" ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.4" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.105.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107" lineNumber="85" text="Monitor renal function periodically in patients receiving eprosartan and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:68" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.2" text="eprosartan" type="Drug"><Normalization><mmtx cui="C0287041" phraseText="eprosartan" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="73:78" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.1"><relations><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.3" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.107.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108" lineNumber="86" text="The antihypertensive effect of angiotensin II receptor antagonists, including eprosartan may be attenuated by NSAIDs including selective COX-2 inhibitors." type="regular"><entity charOffset="31:66" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.1" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:88" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.2" text="eprosartan" type="Drug"><Normalization><mmtx cui="C0287041" phraseText="eprosartan" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="110:116" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.4" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="127:153" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.5" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="4:27|96:106" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.7" text="antihypertensive effect attenuated" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.2" drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.1"/><classClassMembership drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.5"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.4" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.108.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109" lineNumber="87" text="Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics potentiation of orthostatic hypotension may occur. " type="irregular"><entity charOffset="146:185" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.1" text="potentiation of orthostatic hypotension" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="narcotics potentiation of orthostatic hypotension" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><entity charOffset="110:117" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.2" text="Alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="Alcohol," preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="136:145" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.3" text="narcotics" type="Drug_Class"><Normalization><mmtx cui="C0027415" phraseText="narcotics potentiation of orthostatic hypotension" preferredWord="Narcotics" semType="phsu, hops"/><RxNorm RxCui="992359"/></Normalization></entity><entity charOffset="119:131" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.4" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates," preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="90:108" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.5" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.4"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.3"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.4"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110" lineNumber="87" text="Antidiabetic drug (oral agents and insulin) dosage adjustment of the antidiabetic drug may be required. " type="irregular"><anaphoraRelation><anaphoraEntity charOffset="69:86" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.6" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-17" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.1" text="Antidiabetic drug" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:17" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.1" text="Antidiabetic drug" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic drug" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="19:30" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.2" text="oral agents" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="35:42" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.4" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="44:61" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.8" text="dosage adjustment" type="Caution_Interaction"/><classClassMembership drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.2"/><drugClassMembership drug="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.4" drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.1"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.6"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110.e.6"/></sentence><sentence biomedicalEntities="1" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111" lineNumber="87" text="Other antihypertensive drugs additive effect or potentiation. " type="irregular"><entity charOffset="29:60" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111.e.1" text="additive effect or potentiation" type="Increase_Interaction"/><entity charOffset="6:28" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111.e.2" text="antihypertensive drugs" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="Other antihypertensive drugs additive effect" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111.e.2"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111.e.2"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112" text="Cholestyramine and colestipol resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. " type="negative"><entity charOffset="51:70" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="colestipol resins Absorption of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="0:14" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.1" text="cholestyramine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008402" phraseText="Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="19:29" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.2" text="colestipol" type="Biomedical_Entity"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins Absorption of hydrochlorothiazide" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.0"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113" lineNumber="87" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="99:102" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.3" text="its" type="Expression"/><antecedentEntity charOffset="68-87" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.6" text="hydrochlorothiazide" type="Drug"/></anaphoraRelation><entity charOffset="92:98|103:145" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.1" text="reduce absorption from the gastrointestinal tract" type="Decrease_Interaction"/><entity charOffset="41:51" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.2" text="colestipol" type="Drug"><Normalization><mmtx cui="C0009279" phraseText="colestipol resins" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="23:37" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.4" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="Single doses of either cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="68:87" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.6" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.3" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.3" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.1" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.4" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114" lineNumber="87" text="Corticosteroids, ACTH intensified electrolyte depletion, particularly hypokalemia. " type="irregular"><entity charOffset="22:55" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.1" text="intensified electrolyte depletion" type="Specific_Interaction"/><entity charOffset="0:15" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.2" text="Corticosteroids" type="Drug_Class"><Normalization><mmtx cui="C0001617" phraseText="Corticosteroids," preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><entity charOffset="17:21" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.3" text="ACTH" type="Drug"><Normalization><RxNorm RxCui="376"/></Normalization></entity><entity charOffset="70:81" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.5" text="hypokalemia" type="Specific_Interaction"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.3"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.ddi.2"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.3"/></relation><relation type="hasObject"><labelDrug text="Teveten HCT"/><normalization><mmtx><preferredWord>Teveten HCT</preferredWord><phraseText>aliskiren with TEVETEN HCT</phraseText><cuiCode>C1170659</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.2" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115" lineNumber="87" text="Pressor amines (e.g., norepinephrine) possible decreased response to pressor amines but not sufficient to preclude their use. " type="irregular"><entity charOffset="0:14" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.e.1" text="Pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="Pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><entity charOffset="22:36" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.e.2" text="norepinephrine" type="Drug"><Normalization><mmtx cui="C0028351" phraseText="norepinephrine" preferredWord="Norepinephrine" semType="phsu, orch, nsba"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="47:65" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.e.4" text="decreased response" type="Decrease_Interaction"/><entity charOffset="69:83" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.e.5" text="pressor amines" type="Drug_Class"><Normalization><mmtx cui="C0237795" phraseText="possible decreased response to pressor amines" preferredWord="Pressors" semType="phsu"/><RxNorm RxCui="203344"/></Normalization></entity><drugClassMembership drug="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.e.2" drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.e.1"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109" text="Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics potentiation of orthostatic hypotension may occur. "><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.5"/></ellipsisSentence><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110" text="Antidiabetic drug (oral agents and insulin) dosage adjustment of the antidiabetic drug may be required. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111" text="Other antihypertensive drugs additive effect or potentiation. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112" text="Cholestyramine and colestipol resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114" text="Corticosteroids, ACTH intensified electrolyte depletion, particularly hypokalemia. "/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115.e.5"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116" lineNumber="87" text="Skeletal muscle relaxants, nondepolarizing (e.g., tubocurarine) possible increased responsiveness to the muscle relaxant. " type="irregular"><anaphoraRelation><anaphoraEntity charOffset="105:120" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.4" text="muscle relaxant" type="Expression"/><antecedentEntity charOffset="0-42" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.1" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:42" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.1" text="Skeletal muscle relaxants, nondepolarizing" type="Drug_Class"><Normalization><mmtx cui="C0037250" phraseText="Skeletal muscle relaxants," preferredWord="skeletal muscle relaxants" semType="phsu"/><RxNorm RxCui="1427638"/></Normalization></entity><entity charOffset="50:62" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.2" text="tubocurarine" type="Drug"><Normalization><mmtx cui="C0041345" phraseText="tubocurarine" preferredWord="Tubocurarine" semType="phsu, orch"/><RxNorm RxCui="82115"/></Normalization></entity><entity charOffset="73:97" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.6" text="increased responsiveness" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.2" drugClass="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.1"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.6"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109" text="Hydrochlorothiazide: When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics potentiation of orthostatic hypotension may occur. "><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.109.e.5"/></ellipsisSentence><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.110" text="Antidiabetic drug (oral agents and insulin) dosage adjustment of the antidiabetic drug may be required. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.111" text="Other antihypertensive drugs additive effect or potentiation. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.112" text="Cholestyramine and colestipol resins Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.113" text="Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.114" text="Corticosteroids, ACTH intensified electrolyte depletion, particularly hypokalemia. "/><middleSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.115" text="Pressor amines (e.g., norepinephrine) possible decreased response to pressor amines but not sufficient to preclude their use. "/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.116.e.4"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117" lineNumber="87" text="Lithium should not generally be given with diuretics. " type="regular"><entity charOffset="15:37" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.1" text="not generally be given" type="Caution_Interaction"/><entity charOffset="43:52" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.2" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="given with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.3" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.1"><relations><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.2" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118" lineNumber="87" text="Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity. " type="irregular"><entity charOffset="16:42" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.1" text="reduce the renal clearance" type="Increase_Interaction"/><entity charOffset="46:53" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the renal clearance of lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="0:15" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.3" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="85:93" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.5" text="toxicity" type="Increase_Interaction"/><entity charOffset="77:84" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.6" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="a high risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.1"><relations><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.ddi.2"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.5"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117" text="Lithium should not generally be given with diuretics. "><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.117.e.2"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.2" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.118.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.119" text="Refer to the package insert for lithium preparations before use of such preparations with TEVETEN HCT. " type="negative"><entity charOffset="90:101" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.119.e.0" text="teveten hct" type="Biomedical_Entity"><Normalization><mmtx cui="C1170659" phraseText="with TEVETEN HCT." preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><entity charOffset="32:39" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.119.e.1" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.119.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.119.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120" lineNumber="87" text="Nonsteroidal Anti-Inflammatory Drugs in some patients, the administration of a nonsteroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. " type="regular"><entity charOffset="120:139|175:182" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.1" text="reduce the diuretic effects" type="Specific_Interaction"/><entity charOffset="192:209|223:232" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.2" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="186:190|223:232" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.3" text="loop diuretics" type="Drug_Class"><Normalization><mmtx cui="C0597277" phraseText="potassium-sparing" preferredWord="Potassium Ion" semType="phsu, elii"/><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="104215"/></Normalization></entity><entity charOffset="214:232" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.4" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="79:115" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.5" text="nonsteroidal anti-inflammatory agent" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="the administration of a nonsteroidal anti-inflammatory agent" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><mmtx cui="C3536840" phraseText="the administration of a nonsteroidal anti-inflammatory agent" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><entity charOffset="120:130|141:152|175:182" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.7" text="reduce the natriuretic effects" type="Specific_Interaction"/><entity charOffset="120:130|158:182" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.9" text="reduce the antihypertensive effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.1"><relations><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.ddi.2"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.7"><relations><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.ddi.3"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.9"><relations><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.5" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.2" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.5" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.3" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.5" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.4" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.120.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121" lineNumber="87" text="Therefore, when TEVETEN HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained." type="regular"><entity charOffset="116:124" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.1" text="observed" type="Caution_Interaction"/><entity charOffset="32:69" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.2" text="nonsteroidal anti-inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="nonsteroidal anti-inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><entity charOffset="16:27" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.3" text="TEVETEN HCT" type="Drug"><Normalization><mmtx cui="C1170659" phraseText="TEVETEN HCT" preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><drugInteraction id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.ddi.1"><interaction trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.3" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.2" trigger="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.121.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.123" text="No carcinogenicity studies have been conducted with eprosartan mesylate in combination with hydrochlorothiazide. " type="negative"><entity charOffset="92:111" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.123.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="52:71" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.123.e.1" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="conducted with eprosartan mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.123.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.123.e.0"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.124" text="Eprosartan mesylate was not carcinogenic in dietary restricted rats or ad libitum fed mice dosed at 600 mg and 2000 mg eprosartan/kg/day, respectively, for up to 2 years. " type="negative"><entity charOffset="0:19" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.124.e.0" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="Eprosartan mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="119:129" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.124.e.1" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="2000 mg eprosartan/kg/day," preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.124.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.124.e.1"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.125" text="In male and female rats, the systemic exposure (AUC) to unbound eprosartan at the dose evaluated was only approximately 25% of the exposure achieved in humans given TEVETEN HCT. " type="negative"><entity charOffset="64:74" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.125.e.0" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="(AUC) to unbound eprosartan" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="165:176" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.125.e.1" text="teveten hct" type="Biomedical_Entity"><Normalization><mmtx cui="C1170659" phraseText="TEVETEN HCT." preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.125.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.125.e.1"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.126" text="In mice, the systemic exposure (AUC) to unbound eprosartan was approximately 35 times the exposure achieved in humans given TEVETEN HCT. " type="negative"><entity charOffset="124:135" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.126.e.0" text="teveten hct" type="Biomedical_Entity"><Normalization><mmtx cui="C1170659" phraseText="TEVETEN HCT." preferredWord="Teveten HCT" semType="phsu, orch"/><RxNorm RxCui="262242"/></Normalization></entity><entity charOffset="48:58" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.126.e.1" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="(AUC) to unbound eprosartan" preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.126.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.126.e.0"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.130" text="Eprosartan mesylate alone or in combination with hydrochlorothiazide was not mutagenic in vitro in bacteria (Ames test) and did not cause structural chromosomal damage in vivo (mouse micronucleus assay). " type="negative"><entity charOffset="0:19" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.130.e.0" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="Eprosartan mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="49:68" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.130.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.130.e.0" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.130.e.1"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.131" text="In human peripheral lymphocytes in vitro, eprosartan mesylate in combination with hydrochlorothiazide was positive for clastogenicity with and without metabolic activation. " type="negative"><entity charOffset="82:101" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.131.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="42:61" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.131.e.1" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="In human peripheral lymphocytes in vitro, eprosartan mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.131.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.131.e.0"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.135" text="No fertility studies have been conducted with eprosartan mesylate in combination with hydrochlorothiazide. " type="negative"><entity charOffset="86:105" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.135.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="46:65" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.135.e.1" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="conducted with eprosartan mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.135.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.135.e.0"/></sentence><sentence id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.136" text="Eprosartan mesylate had no adverse effects on the reproductive performance of male or female rats at oral doses up to 1000 mg eprosartan/kg/day. " type="negative"><entity charOffset="126:136" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.136.e.0" text="eprosartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0287041" phraseText="up to 1000 mg eprosartan/kg/day." preferredWord="eprosartan" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.136.e.1" text="eprosartan mesylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0772203" phraseText="Eprosartan mesylate" preferredWord="Eprosartan mesylate" semType="phsu, orch"/><RxNorm RxCui="236878"/></Normalization></entity><pair ddi="false" e1="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.136.e.1" e2="Dailymed.de358060-f54a-4f36-a0d5-3f34122aba53.s.136.e.0"/></sentence><positiveExamples number="34"/><negativeExamples number="102"/></document>